CompletedPhase 2NCT02261207
Phase II Study on Axitinib in Advanced Solitary Fibrous Tumor
Studying Solitary fibrous tumor
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
- Principal Investigator
- Silvia Stacchiotti, MDFondazione IRCCS Istituto Nazionale dei Tumori, Milano
- Intervention
- Axitinib(drug)
- Enrollment
- 17 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2014 – 2018
Study locations (1)
- Fondazione IRCCS Istituto Naazionale dei Tumori, Milan, MI, Italy
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02261207 on ClinicalTrials.gov